Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Gastroenterology
•
General Hepatology
•
Alcohol-associated Liver Disease
What pharmacologic therapies do you use to treat alcohol use disorder in a patient with cirrhosis?
Related Questions
When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?
In patients with MASLD, would you consider management with off-label metformin, pioglitazone (despite weight gain risk), GLP-1 RA, or simply intensify lifestyle and monitor?
Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?
How do you approach the treatment of Crohn's colitis in the setting of immunosuppression for liver transplant?
At what BMI or waist-circumference threshold do you opt to move from Fibroscan to other NILDA for fibrosis assessment?
When would you consider use of EUS guided liver biopsy over percutaneous and/or transjugular?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
What is your approach to managing ILD associated with inflammatory bowel disease?
How do you approach the workup for a patient with imaging showing features suggestive of cirrhosis?
How long do you recommend waiting after variceal bleeding and banding before a transesophageal echocardiogram can be performed safely?
